PEZZI, ANNALISA
 Distribuzione geografica
Continente #
NA - Nord America 1.247
EU - Europa 757
AS - Asia 359
AF - Africa 65
SA - Sud America 2
Totale 2.430
Nazione #
US - Stati Uniti d'America 1.241
GB - Regno Unito 229
VN - Vietnam 198
SE - Svezia 119
IT - Italia 109
CN - Cina 108
DE - Germania 95
IE - Irlanda 39
FR - Francia 36
IN - India 31
RU - Federazione Russa 30
UA - Ucraina 27
TG - Togo 22
BG - Bulgaria 20
ZA - Sudafrica 20
CI - Costa d'Avorio 18
EE - Estonia 17
BE - Belgio 12
JO - Giordania 9
CH - Svizzera 8
CA - Canada 6
FI - Finlandia 5
JP - Giappone 5
ES - Italia 3
IR - Iran 3
NG - Nigeria 3
NL - Olanda 3
SC - Seychelles 2
SG - Singapore 2
BR - Brasile 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
HU - Ungheria 1
KR - Corea 1
LB - Libano 1
LV - Lettonia 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
Totale 2.430
Città #
Southend 213
Chandler 175
Fairfield 173
Dong Ket 119
Ashburn 107
Woodbridge 95
Seattle 83
Wilmington 76
Ann Arbor 70
Cambridge 67
Houston 60
Dublin 39
Princeton 38
Bologna 29
Lomé 22
Sofia 20
Bremen 19
Westminster 19
Abidjan 18
Jinan 18
Padova 18
Beijing 16
Berlin 15
Nanjing 15
Brussels 12
Jacksonville 12
San Diego 12
New York 11
Redwood City 11
Saint Petersburg 11
Turin 11
Shenyang 10
Amman 9
Changsha 9
Boardman 7
Florence 6
Hebei 6
Jiaxing 6
Milan 6
Nanchang 6
Paris 5
Tokyo 5
Dearborn 4
Falls Church 4
Helsinki 4
Leawood 4
Los Angeles 4
Romainville 4
Toronto 4
Zhengzhou 4
Bern 3
Geneva 3
Haikou 3
Napoli 3
Norwalk 3
Pune 3
Tianjin 3
Abeokuta 2
Bari 2
Frankfurt am Main 2
Groningen 2
Guangzhou 2
Hockenheim 2
Kuban 2
London 2
Modena 2
Monmouth Junction 2
Munich 2
Mülheim 2
Orange 2
Phoenix 2
Pozzo 2
Redmond 2
Venice 2
Winnipeg 2
Acton 1
Budapest 1
Buffalo 1
Chiswick 1
Falkenstein 1
Fuzhou 1
Hangzhou 1
Hanover 1
Holt 1
Huntington 1
Imola 1
Ingenio 1
Langfang 1
Las Vegas 1
Latina 1
Lausanne 1
Lisbon 1
Ludwigshafen 1
Mahé 1
Mason 1
Medford 1
Mesagne 1
Monreale 1
Muizenberg 1
Ningbo 1
Totale 1.793
Nome #
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease 195
Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment 181
Peripheral neuropathy induced by subcutaneous bortezomib-based induction therapy for newly diagnosed multiple myeloma. 174
Positron emission tomography with computed tomography-based diagnosis of massive extramedullary progression in a patient with high-risk multiple myeloma. 161
Bortezomib and dexamethasone as salvage therapy in patients with relapsed/refractory multiple myeloma: analysis of long-term clinical outcomes 161
The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD) 147
Bortezomib-thalidomide-dexamethasone (VTD) is superior to bortezomib-cyclophosphamide-dexamethasone (VCD) as induction therapy prior to autologous stem cell transplantation in multiple myeloma 138
Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study. 133
Opposite activation of the Hedgehog pathway in CD138+ plasma cells and CD138-CD19+ B cells identifies two subgroups of patients with multiple myeloma and different prognosis 121
Prognostic impact of serial measurements of serum-free light chain assay throughout the course of newly diagnosed multiple myeloma treated with bortezomib-based regimens 115
Combination of international scoring system 3, high lactate dehydrogenase, and t(4;14) and/or del(17p) identifies patients with multiple myeloma (MM) treated with front-line autologous stem-cell transplantation at high risk of early MM progression-related death. 115
Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantation 114
Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma 109
Role of serum free light chain assay in the detection of early relapse and prediction of prognosis after relapse in multiple myeloma patients treated upfront with novel agents 108
Extracellular ATP induces apoptosis through P2X7R activation in acute myeloid leukemia cells but not in normal hematopoietic stem cells 108
PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma 106
Inverse probability weighting to estimate causal effect of a singular phase in a multiphase randomized clinical trial for multiple myeloma 99
Bivalve molluscs and marine environment as tool for monitoring antimicrobial resistance in Salmonella enterica subsp. enterica and Escherichia coli phylogroups: preliminary data from the molluscs production area of Ferrara 98
Relative role ofAPCandMUTYHmutations in the pathogenesis of familial adenomatous polyposis 92
BIVALVE MOLLUSCS AND MARINE ENVIRONMENT AS TOOL FOR MONITORING ANTIMICROBIAL RESISTANCE IN SALMONELLA ENTERICA SUBSP. ENTERICA AND ESCHERICHIA COLI PHYLOGROUPS: PRELIMINARY DATA FROM THE MOLLUSCS PRODUCTION AREA OF FERRARA 20
Totale 2.495
Categoria #
all - tutte 5.415
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.415


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201925 0 0 0 0 0 0 0 0 0 0 12 13
2019/2020703 84 16 2 31 89 69 88 97 96 61 36 34
2020/2021414 67 22 14 10 12 19 14 16 34 12 11 183
2021/2022458 64 30 24 32 34 15 15 24 11 40 81 88
2022/2023563 47 92 29 97 24 53 16 28 98 19 41 19
2023/2024151 13 15 9 25 14 54 6 9 0 6 0 0
Totale 2.495